HIF1A and chronic kidney disease: Accordingly, the potential effect of ASP on the enhancement of HIF-1/2α proteins in CKD rats could be attributed to the direct blockage of protein degradation we describe in the cells, and probably also to the anti-inflammatory activity of ASP, which would prevent the activation of PHDs mediated by inflammation.